Statinintoleranz und statinassoziierte Muskelschmerzen View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-04-22

AUTHORS

Paulina Elena Stürzebecher, Friederike Schumann, Ursula Kassner, Ulrich Laufs

ABSTRACT

Statins are among the best studied drugs. Due to the extensive evidence regarding efficacy and safety, they are the cornerstone of lipid-lowering therapy. While the tolerability of statins in large blinded studies is at the placebo level, so-called statin intolerance (SI) is a frequent and complex problem in everyday clinical practice. Statin-associated muscular pain (SAMS) is most commonly reported. In many cases SI is associated with inadequate lowering of low-density lipoprotein (LDL) cholesterol (LDL-C), thereby increasing the cardiovascular risk. The diagnosis of SAMS is based on the exclusion of possible alternative causes of muscular symptoms and the exclusion of nocebo effects through a diagnostic strategy of discontinuation of statin treatment, observation and assessment of symptoms, followed by renewed administration of a different statin initially at a low dose with subsequent dose increase. A large proportion of patients with SI and SAMS can take statins permanently and without discomfort by this approach. If LDL‑C lowering is insufficient, combination therapies are used. It is an important task of the prescribing physicians and all those involved in the treatment to increase the adherence to statins through appropriate communication. Numerous questions on SI remain open and are being addressed by an ongoing register. More... »

PAGES

204-211

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00059-022-05114-w

DOI

http://dx.doi.org/10.1007/s00059-022-05114-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1147317492

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35451596


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol, LDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Muscular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pain", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Klinik und Poliklinik f\u00fcr Kardiologie, Universit\u00e4tsklinikum Leipzig, 04103, Leipzig, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.411339.d", 
          "name": [
            "Klinik und Poliklinik f\u00fcr Kardiologie, Universit\u00e4tsklinikum Leipzig, 04103, Leipzig, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "St\u00fcrzebecher", 
        "givenName": "Paulina Elena", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medizinische Klinik f\u00fcr Endokrinologie, Diabetes und Ern\u00e4hrungsmedizin \u2013\u00a0Arbeitsbereich Lipidstoffwechsel, Charit\u00e9\u00a0\u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.6363.0", 
          "name": [
            "Medizinische Klinik f\u00fcr Endokrinologie, Diabetes und Ern\u00e4hrungsmedizin \u2013\u00a0Arbeitsbereich Lipidstoffwechsel, Charit\u00e9\u00a0\u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schumann", 
        "givenName": "Friederike", 
        "id": "sg:person.014011143420.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014011143420.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medizinische Klinik f\u00fcr Endokrinologie, Diabetes und Ern\u00e4hrungsmedizin \u2013\u00a0Arbeitsbereich Lipidstoffwechsel, Charit\u00e9\u00a0\u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.6363.0", 
          "name": [
            "Medizinische Klinik f\u00fcr Endokrinologie, Diabetes und Ern\u00e4hrungsmedizin \u2013\u00a0Arbeitsbereich Lipidstoffwechsel, Charit\u00e9\u00a0\u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kassner", 
        "givenName": "Ursula", 
        "id": "sg:person.01325504626.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325504626.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik und Poliklinik f\u00fcr Kardiologie, Universit\u00e4tsklinikum Leipzig, 04103, Leipzig, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.411339.d", 
          "name": [
            "Klinik und Poliklinik f\u00fcr Kardiologie, Universit\u00e4tsklinikum Leipzig, 04103, Leipzig, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laufs", 
        "givenName": "Ulrich", 
        "id": "sg:person.01316611454.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316611454.23"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00108-021-01059-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1138983069", 
          "https://doi.org/10.1007/s00108-021-01059-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1008-1050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041627528", 
          "https://doi.org/10.1038/nm1008-1050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10557-017-6723-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084904553", 
          "https://doi.org/10.1007/s10557-017-6723-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-020-01740-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1130966110", 
          "https://doi.org/10.1007/s00392-020-01740-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-04-22", 
    "datePublishedReg": "2022-04-22", 
    "description": "Statins are among the best studied drugs. Due to the extensive evidence regarding efficacy and safety, they are the cornerstone of lipid-lowering therapy. While the tolerability of statins in large blinded studies is at the placebo level, so-called statin intolerance (SI) is a\u00a0frequent and complex problem in everyday clinical practice. Statin-associated muscular pain (SAMS) is most commonly reported. In many cases SI is associated with inadequate lowering of low-density lipoprotein (LDL) cholesterol (LDL-C), thereby increasing the cardiovascular risk. The diagnosis of SAMS is based on the exclusion of possible alternative causes of muscular symptoms and the exclusion of nocebo effects through a\u00a0diagnostic strategy of discontinuation of statin treatment, observation and assessment of symptoms, followed by renewed administration of a\u00a0different statin initially at a\u00a0low dose with subsequent dose increase. A\u00a0large proportion of patients with SI and SAMS can take statins permanently and without discomfort by this approach. If LDL\u2011C lowering is insufficient, combination therapies are used. It is an important task of the prescribing physicians and all those involved in the treatment to increase the adherence to statins through appropriate communication. Numerous questions on SI remain open and are being addressed by an ongoing register.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00059-022-05114-w", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1087175", 
        "issn": [
          "0340-9937", 
          "1615-6692"
        ], 
        "name": "Herz", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "keywords": [
      "statin intolerance", 
      "low-density lipoprotein cholesterol", 
      "tolerability of statins", 
      "lipid-lowering therapy", 
      "LDL-C lowering", 
      "assessment of symptoms", 
      "everyday clinical practice", 
      "subsequent dose increase", 
      "inadequate lowering", 
      "lipoprotein cholesterol", 
      "cardiovascular risk", 
      "statin treatment", 
      "muscular symptoms", 
      "placebo levels", 
      "combination therapy", 
      "muscular pain", 
      "possible alternative causes", 
      "different statins", 
      "low dose", 
      "statins", 
      "blinded study", 
      "clinical practice", 
      "diagnostic strategies", 
      "large blinded study", 
      "alternative causes", 
      "nocebo effects", 
      "dose increase", 
      "ongoing register", 
      "therapy", 
      "symptoms", 
      "treatment", 
      "extensive evidence", 
      "large proportion", 
      "appropriate communication", 
      "tolerability", 
      "discontinuation", 
      "pain", 
      "patients", 
      "intolerance", 
      "physicians", 
      "cholesterol", 
      "diagnosis", 
      "administration", 
      "dose", 
      "drugs", 
      "discomfort", 
      "adherence", 
      "efficacy", 
      "risk", 
      "cause", 
      "Register", 
      "numerous questions", 
      "lowering", 
      "safety", 
      "exclusion", 
      "proportion", 
      "cornerstone", 
      "assessment", 
      "evidence", 
      "SAMS", 
      "levels", 
      "study", 
      "increase", 
      "effect", 
      "practice", 
      "strategies", 
      "observations", 
      "questions", 
      "approach", 
      "communication", 
      "task", 
      "complex problems", 
      "problem", 
      "important task"
    ], 
    "name": "Statinintoleranz und statinassoziierte Muskelschmerzen", 
    "pagination": "204-211", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1147317492"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00059-022-05114-w"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35451596"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00059-022-05114-w", 
      "https://app.dimensions.ai/details/publication/pub.1147317492"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_933.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00059-022-05114-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05114-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05114-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05114-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05114-w'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      108 URIs      96 LITERALS      12 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00059-022-05114-w schema:about N0e42b15fcc074efea4712ed622f13496
2 N1eee67778d4d4e81aefc62bd8e259507
3 N45c3ba2a529d430793713e2bf075b08f
4 Nc7b7c21f4e6b478593b0f77c7f0c89f1
5 Nd6159139e11145c3b9e9a2659b672e51
6 anzsrc-for:11
7 anzsrc-for:1103
8 schema:author Ne870085d50784e58aeae005ce71829d3
9 schema:citation sg:pub.10.1007/s00108-021-01059-0
10 sg:pub.10.1007/s00392-020-01740-8
11 sg:pub.10.1007/s10557-017-6723-4
12 sg:pub.10.1038/nm1008-1050
13 schema:datePublished 2022-04-22
14 schema:datePublishedReg 2022-04-22
15 schema:description Statins are among the best studied drugs. Due to the extensive evidence regarding efficacy and safety, they are the cornerstone of lipid-lowering therapy. While the tolerability of statins in large blinded studies is at the placebo level, so-called statin intolerance (SI) is a frequent and complex problem in everyday clinical practice. Statin-associated muscular pain (SAMS) is most commonly reported. In many cases SI is associated with inadequate lowering of low-density lipoprotein (LDL) cholesterol (LDL-C), thereby increasing the cardiovascular risk. The diagnosis of SAMS is based on the exclusion of possible alternative causes of muscular symptoms and the exclusion of nocebo effects through a diagnostic strategy of discontinuation of statin treatment, observation and assessment of symptoms, followed by renewed administration of a different statin initially at a low dose with subsequent dose increase. A large proportion of patients with SI and SAMS can take statins permanently and without discomfort by this approach. If LDL‑C lowering is insufficient, combination therapies are used. It is an important task of the prescribing physicians and all those involved in the treatment to increase the adherence to statins through appropriate communication. Numerous questions on SI remain open and are being addressed by an ongoing register.
16 schema:genre article
17 schema:isAccessibleForFree true
18 schema:isPartOf N804c49c220324f79a4a5c86dea561634
19 Nf004925a5da0432ab9e690aa86bacf64
20 sg:journal.1087175
21 schema:keywords LDL-C lowering
22 Register
23 SAMS
24 adherence
25 administration
26 alternative causes
27 approach
28 appropriate communication
29 assessment
30 assessment of symptoms
31 blinded study
32 cardiovascular risk
33 cause
34 cholesterol
35 clinical practice
36 combination therapy
37 communication
38 complex problems
39 cornerstone
40 diagnosis
41 diagnostic strategies
42 different statins
43 discomfort
44 discontinuation
45 dose
46 dose increase
47 drugs
48 effect
49 efficacy
50 everyday clinical practice
51 evidence
52 exclusion
53 extensive evidence
54 important task
55 inadequate lowering
56 increase
57 intolerance
58 large blinded study
59 large proportion
60 levels
61 lipid-lowering therapy
62 lipoprotein cholesterol
63 low dose
64 low-density lipoprotein cholesterol
65 lowering
66 muscular pain
67 muscular symptoms
68 nocebo effects
69 numerous questions
70 observations
71 ongoing register
72 pain
73 patients
74 physicians
75 placebo levels
76 possible alternative causes
77 practice
78 problem
79 proportion
80 questions
81 risk
82 safety
83 statin intolerance
84 statin treatment
85 statins
86 strategies
87 study
88 subsequent dose increase
89 symptoms
90 task
91 therapy
92 tolerability
93 tolerability of statins
94 treatment
95 schema:name Statinintoleranz und statinassoziierte Muskelschmerzen
96 schema:pagination 204-211
97 schema:productId N14940de4ff3c4f3f9fe7832afaa1d222
98 N2469ea5c5e304e58bbbe329db98607ed
99 Nb4164fd028554d8f8b20540de00972aa
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1147317492
101 https://doi.org/10.1007/s00059-022-05114-w
102 schema:sdDatePublished 2022-10-01T06:50
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N0a580ce4765141df9c46f9bd7d5646d8
105 schema:url https://doi.org/10.1007/s00059-022-05114-w
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N0a580ce4765141df9c46f9bd7d5646d8 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N0db8b0a5c35349f681dd504e62989b1f schema:affiliation grid-institutes:grid.411339.d
112 schema:familyName Stürzebecher
113 schema:givenName Paulina Elena
114 rdf:type schema:Person
115 N0e42b15fcc074efea4712ed622f13496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
117 rdf:type schema:DefinedTerm
118 N14940de4ff3c4f3f9fe7832afaa1d222 schema:name doi
119 schema:value 10.1007/s00059-022-05114-w
120 rdf:type schema:PropertyValue
121 N1eee67778d4d4e81aefc62bd8e259507 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Pain
123 rdf:type schema:DefinedTerm
124 N2469ea5c5e304e58bbbe329db98607ed schema:name pubmed_id
125 schema:value 35451596
126 rdf:type schema:PropertyValue
127 N2833f714edc74b9da52fcf5e60c1d8af rdf:first sg:person.01325504626.30
128 rdf:rest Nd8d1229afea04f83be0d3d5a4b67996a
129 N45c3ba2a529d430793713e2bf075b08f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Humans
131 rdf:type schema:DefinedTerm
132 N46ff6bdcf1ec47699969b24e28e718fb rdf:first sg:person.014011143420.54
133 rdf:rest N2833f714edc74b9da52fcf5e60c1d8af
134 N804c49c220324f79a4a5c86dea561634 schema:issueNumber 3
135 rdf:type schema:PublicationIssue
136 Nb4164fd028554d8f8b20540de00972aa schema:name dimensions_id
137 schema:value pub.1147317492
138 rdf:type schema:PropertyValue
139 Nc7b7c21f4e6b478593b0f77c7f0c89f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Muscular Diseases
141 rdf:type schema:DefinedTerm
142 Nd6159139e11145c3b9e9a2659b672e51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Cholesterol, LDL
144 rdf:type schema:DefinedTerm
145 Nd8d1229afea04f83be0d3d5a4b67996a rdf:first sg:person.01316611454.23
146 rdf:rest rdf:nil
147 Ne870085d50784e58aeae005ce71829d3 rdf:first N0db8b0a5c35349f681dd504e62989b1f
148 rdf:rest N46ff6bdcf1ec47699969b24e28e718fb
149 Nf004925a5da0432ab9e690aa86bacf64 schema:volumeNumber 47
150 rdf:type schema:PublicationVolume
151 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
152 schema:name Medical and Health Sciences
153 rdf:type schema:DefinedTerm
154 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
155 schema:name Clinical Sciences
156 rdf:type schema:DefinedTerm
157 sg:journal.1087175 schema:issn 0340-9937
158 1615-6692
159 schema:name Herz
160 schema:publisher Springer Nature
161 rdf:type schema:Periodical
162 sg:person.01316611454.23 schema:affiliation grid-institutes:grid.411339.d
163 schema:familyName Laufs
164 schema:givenName Ulrich
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316611454.23
166 rdf:type schema:Person
167 sg:person.01325504626.30 schema:affiliation grid-institutes:grid.6363.0
168 schema:familyName Kassner
169 schema:givenName Ursula
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325504626.30
171 rdf:type schema:Person
172 sg:person.014011143420.54 schema:affiliation grid-institutes:grid.6363.0
173 schema:familyName Schumann
174 schema:givenName Friederike
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014011143420.54
176 rdf:type schema:Person
177 sg:pub.10.1007/s00108-021-01059-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1138983069
178 https://doi.org/10.1007/s00108-021-01059-0
179 rdf:type schema:CreativeWork
180 sg:pub.10.1007/s00392-020-01740-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130966110
181 https://doi.org/10.1007/s00392-020-01740-8
182 rdf:type schema:CreativeWork
183 sg:pub.10.1007/s10557-017-6723-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084904553
184 https://doi.org/10.1007/s10557-017-6723-4
185 rdf:type schema:CreativeWork
186 sg:pub.10.1038/nm1008-1050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041627528
187 https://doi.org/10.1038/nm1008-1050
188 rdf:type schema:CreativeWork
189 grid-institutes:grid.411339.d schema:alternateName Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103, Leipzig, Deutschland
190 schema:name Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103, Leipzig, Deutschland
191 rdf:type schema:Organization
192 grid-institutes:grid.6363.0 schema:alternateName Medizinische Klinik für Endokrinologie, Diabetes und Ernährungsmedizin – Arbeitsbereich Lipidstoffwechsel, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Deutschland
193 schema:name Medizinische Klinik für Endokrinologie, Diabetes und Ernährungsmedizin – Arbeitsbereich Lipidstoffwechsel, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Deutschland
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...